Sign In
News Digest /
Ticker: UTHR
Ticker: UTHR
07:02am, Wednesday, Jul 30, 2025
United Therapeutics Corporation (NASDAQ: UTHR) - Q2 2025 Financial Overview
United Therapeutics continues to advance its mission in the biopharmaceutical sector, with notable developments in revenues, expenses, and ongoing challenges. Below are the key highlights and analysis of their recent inco...
09:24am, Monday, Jun 02, 2025
Liquidia Technologies (LQDA) shares surged 9.6% after announcing the commercial shipment of YUTREPIA™, a treatment for pulmonary hypertension. A favorable court ruling further enhances investor confidence, marking a key milestone for the company.
07:01am, Wednesday, Apr 30, 2025
Company Overview:
United Therapeutics Corporation (NASDAQ: UTHR) is a biotechnology company focused on developing innovative therapies for chronic and life-threatening conditions. The company aims to meet unmet medical needs through its range of products, including multiple formulations of trepro...
08:27am, Tuesday, Aug 20, 2024
Explore 3 healthcare stocks worth watching in September, with net profit margins over 10%, YTD gains up to 65%, and strong EBITDA margins.
08:47am, Monday, Aug 19, 2024
Liquidia Corporation (NASDAQ: LQDA) faced a 40% stock drop after the FDA delayed approval for its inhaled drug yutrepia due to United Therapeutics' exclusivity on Tyvaso DPI. The situation highlights the volatility in biopharma investments amid patent disputes.